Trevi Therapeutics, Inc. Common Stock

TRVI US89532M1018

💰
Capitalization
Small-cap

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

🔗
Website
https://www.trevitherapeutics.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
15
🙍
Insiders
4
Person Price Shares Total Published Completed
Good Jennifer L
CEO 		6.58
USD 		5,263
Sold 		34,625
USD 		21/03/2025 21/03/2025
Good Jennifer L
CEO 		3.04
USD 		1,840
Sold 		5,587
USD 		06/09/2024 09/09/2024
Good Jennifer L
CEO 		3.03
USD 		4,219
Sold 		12,784
USD 		06/09/2024 06/09/2024
Good Jennifer L
CEO 		3.11
USD 		40,277
Sold 		125,310
USD 		03/09/2024 05/09/2024
Good Jennifer L
CEO 		3.02
USD 		10,981
Sold 		33,205
USD 		03/09/2024 04/09/2024
Good Jennifer L
CEO 		3.02
USD 		3,863
Sold 		11,677
USD 		03/09/2024 03/09/2024
Meeker David P
 2.93
USD 		4,555
Sold 		13,353
USD 		27/08/2024 27/08/2024
Sciascia Thomas
CSO 		2.96
USD 		16,496
Sold 		48,883
USD 		19/08/2024 19/08/2024
Sciascia Thomas
CSO 		2.76
USD 		18,660
Sold 		51,440
USD 		14/08/2024 16/08/2024
Sciascia Thomas
CSO 		2.79
USD 		12,745
Sold 		35,513
USD 		14/08/2024 15/08/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Trevi Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Good Jennifer L 8 308,040.46 38,505.06 10/05/2024 21/03/2025
Sciascia Thomas 5 272,220.04 54,444.01 29/05/2024 19/08/2024
Meeker David P 1 13,352.53 13,352.53 27/08/2024 27/08/2024
Delfini Lisa 1 11,484.87 11,484.87 22/05/2024 22/05/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
Rhythm Pharmaceuticals, Inc. US76243J1051 RYTM

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.